Drug safety watch: study tracks side effects in hundreds of japanese lung patients
NCT ID NCT04559581
Summary
This study aimed to monitor the safety of the drug Ofev in real-world patients in Japan with a specific type of progressive, scarring lung disease. It tracked 425 patients who were newly prescribed Ofev to see what side effects, especially liver problems, they experienced. The goal was to gather safety information after the drug was approved and being used in regular medical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG DISEASES, INTERSTITIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nippon Boehringer Ingelheim Co., Ltd.
Tokyo, 1416017, Japan
Conditions
Explore the condition pages connected to this study.